Meeting
2024 ASCO Genitourinary Cancers Symposium
Clinical outcomes of frontline GemFLP in advanced urachal and non-urachal adenocarcinomas of the urinary tract: The MD Anderson Cancer Center (MDACC) experience.
Authors
Mohammad Jad Moussa
Department of Genitourinary Medical Oncology, The University of Texas MD Anderson Cancer Center, Houston, TX
Mohammad Jad Moussa , Adrienne H. Chen , Allison K. Grana , Jianjun Gao , Amishi Yogesh Shah , Paul Gettys Corn , Nizar M. Tannir , Sangeeta Goswami , Jianbo Wang , John C. Araujo , Ashish M. Kamat , Neema Navai , Curtis Alvin Pettaway , Mehrad Adibi , Bogdan Czerniak , Charles C. Guo , Arlene O. Siefker-Radtke , Matthew T Campbell , Omar Alhalabi
Disclaimer
This material on this page is ©2024 American Society of Clinical Oncology, all rights reserved. Licensing available upon request. For more information, please contact licensing@asco.org
Poster Details
Session Type
Poster Session
Session Title
Poster Session B: Urothelial Carcinoma
Track
Urothelial Carcinoma
Sub Track
Therapeutics
Citation
J Clin Oncol 42, 2024 (suppl 4; abstr 630)
DOI
10.1200/JCO.2024.42.4_suppl.630
Abstract #
630
Poster Bd #
H15
Abstract Disclosures
Similar Posters
Poster
2018 ASCO Annual Meeting
Liposomal irinotecan (nal-IRI) plus 5-fluorouracil (5-FU) and leucovorin (LV) or gemcitabine plus cisplatin in advanced cholangiocarcinoma: The AIO-NIFE-trial, an open label, randomized, multicenter phase II trial.
First Author: Thomas Jens Ettrich
Poster
2017 Gastrointestinal Cancers Symposium
A single arm, prospective multicenter phase II study FOLFIRINOX in patients with advanced and recurrent biliary tract cancer.
First Author: Naminatsu Takahara
Poster
2023 ASCO Genitourinary Cancers Symposium
A phase II trial of pembrolizumab combined with platinum-based chemotherapy as first-line systemic therapy in advanced penile cancer: HERCULES (LACOG 0218) trial.
First Author: Fernando Cotait Maluf
Poster
2023 ASCO Gastrointestinal Cancers Symposium
Interim analysis results of gut microbiota in patients with unresectable cholangiopancreatic cancer: SCRUM-Japan MONSTAR-SCREEN.
First Author: Shun Tezuka